Literature DB >> 14974919

Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome).

Issahar Ben-Dov1, Mark Gaides, Mickey Scheinowitz, Rivka Wagner, Zvi Laron.   

Abstract

OBJECTIVE: Primary IGF-I deficiency (Laron syndrome, LS) may decrease exercise capacity as a result of a lack of an IGF-I effect on heart, peripheral muscle or lung structure and/or function.
METHODS: Eight patients (six females) who had never received treatment with IGF-I, with mean age of 36 +/- 10 (SD) years (range 21-48), weight 47 +/- 9 kg (31-61), height 126 +/- 12 cm (112-140) and body mass index of 29 +/- 4 kg/m2 (24-34), and 12 age-matched controls, underwent lung function tests and incremental cycling to the limit of tolerance (CPX, MedGraphics). Predicted values for the patients were derived from adult equations based on height.
RESULTS: In LS patients, lung function was near normal; vital capacity was 84 +/- 11% of expected (66-103). Peak exercise O2-uptake and the anaerobic threshold were reduced, 57 +/- 20% of predicted and 33 +/- 9% of predicted peak (P = 0.005 vs. controls), despite normal mean exercise breathing reserve. All parameters were normal in the controls.
CONCLUSION: Exercise capacity in untreated adults with LS is significantly reduced. The limitation for most patients was not ventilatory but resulted either from low cardiac output and/or from dysfunction of the peripheral muscles. However, the relative contribution of each of these elements and/or the role of poor fitness needs further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14974919     DOI: 10.1046/j.1365-2265.2003.01920.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

Review 1.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

Authors:  Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

Review 2.  The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances.

Authors:  Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

3.  Cardiac-Specific Disruption of GH Receptor Alters Glucose Homeostasis While Maintaining Normal Cardiac Performance in Adult Male Mice.

Authors:  Adam Jara; Xingbo Liu; Don Sim; Chance M Benner; Silvana Duran-Ortiz; Yanrong Qian; Edward O List; Darlene E Berryman; Jason K Kim; John J Kopchick
Journal:  Endocrinology       Date:  2016-04-01       Impact factor: 4.736

4.  Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor.

Authors:  Peter Klover; Weiping Chen; Bing-Mei Zhu; Lothar Hennighausen
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

5.  Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case report.

Authors:  Oana R Cotta; Libero Santarpia; Lorenzo Curtò; Gianluca Aimaretti; Ginevra Corneli; Francesco Trimarchi; Salvatore Cannavò
Journal:  J Med Case Rep       Date:  2011-07-11

Review 6.  Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.

Authors:  Zheng Wang; Wenting Li; Qiongya Guo; Yuming Wang; Lijun Ma; Xiaoju Zhang
Journal:  Biomed Res Int       Date:  2018-06-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.